DK1023263T3 - Nye vitamin D analoger - Google Patents

Nye vitamin D analoger

Info

Publication number: DK1023263T3
Authority: DK; Denmark
Prior art keywords: carbon atom; hydroxy; hydrogen; groups; hydrocarbylene
Prior art date: 1997-10-06

Application number

DK98947397T

Other languages

Danish (da)

English (en)

Inventor

Daehne Welf Von

Martin John Calverley

Claus Aage Svensgaard Bretting

Gunnar Grue-Sorensen

Original Assignee

Leo Pharma As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-06

Filing date

1998-10-02

Publication date

2002-12-02

1998-10-02 Application filed by Leo Pharma As filed Critical Leo Pharma As

2002-12-02 Application granted granted Critical

2002-12-02 Publication of DK1023263T3 publication Critical patent/DK1023263T3/da

Links

229930003316 Vitamin D Natural products 0.000 title 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title 1
235000019166 vitamin D Nutrition 0.000 title 1
239000011710 vitamin D Substances 0.000 title 1
150000003710 vitamin D derivatives Chemical class 0.000 title 1
229940046008 vitamin d Drugs 0.000 title 1
229910052799 carbon Inorganic materials 0.000 abstract 3
125000004432 carbon atom Chemical group C* 0.000 abstract 3
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 2
125000000743 hydrocarbylene group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
125000004429 atom Chemical group 0.000 abstract 1
125000002837 carbocyclic group Chemical group 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
230000004663 cell proliferation Effects 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
230000001506 immunosuppresive effect Effects 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000004430 oxygen atom Chemical group O* 0.000 abstract 1
125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
229930195734 saturated hydrocarbon Natural products 0.000 abstract 1
210000004881 tumor cell Anatomy 0.000 abstract 1
229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Hematology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK98947397T 1997-10-06 1998-10-02 Nye vitamin D analoger DK1023263T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9721156.9A GB9721156D0 (en)	1997-10-06	1997-10-06	Novel vitamin d analogues
PCT/DK1998/000423 WO1999018070A1 (en)	1997-10-06	1998-10-02	Novel vitamin d analogues

Publications (1)

Publication Number	Publication Date
DK1023263T3 true DK1023263T3 (da)	2002-12-02

Family

ID=10820110

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98947397T DK1023263T3 (da)	1997-10-06	1998-10-02	Nye vitamin D analoger

Country Status (19)

Country	Link
US (1)	US6399797B1 (pl)
EP (1)	EP1023263B1 (pl)
JP (1)	JP2001519327A (pl)
KR (1)	KR20010030966A (pl)
CN (1)	CN1140509C (pl)
AT (1)	ATE219053T1 (pl)
AU (1)	AU740457B2 (pl)
CA (1)	CA2304152A1 (pl)
CZ (1)	CZ295955B6 (pl)
DE (1)	DE69806035T2 (pl)
DK (1)	DK1023263T3 (pl)
ES (1)	ES2175784T3 (pl)
GB (1)	GB9721156D0 (pl)
HU (1)	HUP0004226A3 (pl)
NZ (1)	NZ503344A (pl)
PL (1)	PL193060B1 (pl)
PT (1)	PT1023263E (pl)
RU (1)	RU2196132C2 (pl)
WO (1)	WO1999018070A1 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2404335C (en) *	2000-03-27	2009-01-06	Wisconsin Alumni Research Foundation	Vitamin d compounds used to stabilize kidney transplants
EP1458678A1 (en) *	2002-11-18	2004-09-22	Teva Pharmaceutical Industries Limited	A crystallization method for purification of calcipotriene
EP1812011A1 (en)	2004-11-12	2007-08-01	Bioxell S.p.a.	Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
ES2344989T3 (es) *	2004-11-22	2010-09-13	Wisconsin Alumni Research Foundation	Analogos de 17,20(e)-deshidro vitamina d y sus usos.
US8193169B2 (en) *	2006-04-06	2012-06-05	Wisconsin Alumni Research Foundation	(20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
KR20110113664A (ko) *	2006-08-29	2011-10-17	테바 파마슈티컬 인더스트리즈 리미티드	비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
US7879829B2 (en) *	2008-07-10	2011-02-01	Wisconsin Alumni Research Foundation	19-nor-vitamin D analogs with 1,2-dihydrofuran ring
US7713953B2 (en) *	2008-07-10	2010-05-11	Wisconsin Alumni Research Foundation	2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
US7893043B2 (en)	2008-07-10	2011-02-22	Wisconsin Alumni Research Foundation	2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
US7888339B2 (en)	2008-07-10	2011-02-15	Wisconsin Alumni Research Foundation	2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
US8399439B2 (en)	2008-07-10	2013-03-19	Wisconsin Alumni Research Foundation	2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
US7648974B1 (en) *	2008-07-10	2010-01-19	Wisconsin Alumni Research Foundation	19-nor-vitamin D analogs with 3,2-dihydrofuran ring
US8193170B2 (en)	2008-07-10	2012-06-05	Wisconsin Alumni Research Foundation	2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US8222236B2 (en) *	2008-07-10	2012-07-17	Wisconsin Alumni Research Foundation	2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
AU2010208323B2 (en)	2009-01-27	2016-03-10	Berg Llc	Vitamin D3 and analogs thereof for alleviating side effects associated with chemotherapy
EP2464357B1 (en)	2009-08-14	2019-05-22	Berg LLC	Vitamin d3 and analogs thereof for treating alopecia
WO2011041579A2 (en)	2009-10-02	2011-04-07	Wisconsin Alumni Research Foundation	(20S,22E)-2-METHYLENE-19-NOR-22-ENE-1α,25-DIHYDROXYVITAMIN D3 ANALOGS
WO2011041596A2 (en)	2009-10-02	2011-04-07	Wisconsin Alumni Research Foundation	19-nor-vitamin d analogs with 1,2-or 3,2-cyclopentene ring
JP6059716B2 (ja)	2011-06-03	2017-01-11	ウイスコンシンアラムニリサーチファンデーション	（２２Ｅ）−２−メチレン−２６，２７−シクロ−２２−デヒドロ−１α−ヒドロキシ−１９−ノルビタミンＤ３誘導体
WO2013003307A1 (en)	2011-06-28	2013-01-03	Wisconsin Alumni Research Foundation	2-methylene-(22e)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs
US20130178449A1 (en)	2011-07-18	2013-07-11	Wisconsin Alumni Research Foundation	2-Methylene-20(21)-Dehydro-19,24,25,26,27-Pentanor-Vitamin D Analogs
US9416102B2 (en)	2013-01-23	2016-08-16	Wisconsin Alumni Research Foundation	(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs
SG10201709894RA (en)	2013-05-29	2018-01-30	Berg Llc	Preventing or mitigating chemotherapy induced alopecia using vitamin d
CN114593917A (zh) *	2022-03-08	2022-06-07	安徽理工大学	一种基于三元组模型的小样本轴承故障诊断方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2091515T3 (es) *	1992-05-20	1996-11-01	Hoffmann La Roche	Analogos fluorados de la vitamina d3.
GB9214202D0 (en) *	1992-07-03	1992-08-12	Leo Pharm Prod Ltd	Chemical compounds
US5565589A (en)	1993-11-03	1996-10-15	Wisconsin Alumni Research Foundation	17-formyl-5,6-trans-vitamin D compounds
ES2130522T3 (es) *	1994-12-14	1999-07-01	Duphar Int Res	Compuestos de vitamina d y metodo para preparar estos compuestos.

1997
- 1997-10-06 GB GBGB9721156.9A patent/GB9721156D0/en not_active Ceased
1998
- 1998-10-02 PT PT98947397T patent/PT1023263E/pt unknown
- 1998-10-02 NZ NZ503344A patent/NZ503344A/en unknown
- 1998-10-02 ES ES98947397T patent/ES2175784T3/es not_active Expired - Lifetime
- 1998-10-02 RU RU2000111255/04A patent/RU2196132C2/ru not_active IP Right Cessation
- 1998-10-02 CZ CZ20001178A patent/CZ295955B6/cs not_active IP Right Cessation
- 1998-10-02 AU AU94323/98A patent/AU740457B2/en not_active Ceased
- 1998-10-02 CN CNB988099330A patent/CN1140509C/zh not_active Expired - Fee Related
- 1998-10-02 KR KR1020007003717A patent/KR20010030966A/ko not_active Ceased
- 1998-10-02 HU HU0004226A patent/HUP0004226A3/hu unknown
- 1998-10-02 AT AT98947397T patent/ATE219053T1/de not_active IP Right Cessation
- 1998-10-02 CA CA002304152A patent/CA2304152A1/en not_active Abandoned
- 1998-10-02 PL PL339668A patent/PL193060B1/pl unknown
- 1998-10-02 DE DE69806035T patent/DE69806035T2/de not_active Expired - Fee Related
- 1998-10-02 JP JP2000514882A patent/JP2001519327A/ja active Pending
- 1998-10-02 DK DK98947397T patent/DK1023263T3/da active
- 1998-10-02 WO PCT/DK1998/000423 patent/WO1999018070A1/en not_active Ceased
- 1998-10-02 US US09/543,418 patent/US6399797B1/en not_active Expired - Fee Related
- 1998-10-02 EP EP98947397A patent/EP1023263B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1023263B1 (en)	2002-06-12
HUP0004226A2 (hu)	2001-04-28
CA2304152A1 (en)	1999-04-15
HUP0004226A3 (en)	2001-10-29
EP1023263A1 (en)	2000-08-02
PT1023263E (pt)	2002-10-31
PL339668A1 (en)	2001-01-02
JP2001519327A (ja)	2001-10-23
HK1031868A1 (zh)	2001-06-29
DE69806035D1 (de)	2002-07-18
PL193060B1 (pl)	2007-01-31
GB9721156D0 (en)	1997-12-03
NZ503344A (en)	2002-04-26
KR20010030966A (ko)	2001-04-16
RU2196132C2 (ru)	2003-01-10
DE69806035T2 (de)	2003-01-30
AU9432398A (en)	1999-04-27
CN1274344A (zh)	2000-11-22
ES2175784T3 (es)	2002-11-16
CN1140509C (zh)	2004-03-03
CZ20001178A3 (cs)	2000-09-13
AU740457B2 (en)	2001-11-01
US6399797B1 (en)	2002-06-04
ATE219053T1 (de)	2002-06-15
CZ295955B6 (cs)	2005-12-14
WO1999018070A1 (en)	1999-04-15

Publication	Publication Date	Title
PT1023263E (pt)	2002-10-31	Novos analogos de vitamina d
MY141803A (en)	2010-06-30	Solid catalyst component for polymerization of olefins, catalyst comprising the same and use thereof
PE20000136A1 (es)	2000-03-11	Proceso para la sintesis de 1,3-dioles
DK0633878T3 (da)	1997-04-21	Nye D-vitaminanaloger
MY143267A (en)	2011-04-15	Metal corrosion inhibitor and hydrogen chloride formation inhibitor in a crude oil atmospheric distillation unit
ES2189476T3 (es)	2003-07-01	Odorizado de gases.
JPS5231995A (en)	1977-03-10	Gas generator
ATE150013T1 (de)	1997-03-15	Vitamin d derivate
ES2142582T3 (es)	2000-04-16	Organosilicona que tiene un grupo funcional carboxilo.
BR9803887A (pt)	2000-03-28	Macrociclos.
ES2144029T3 (es)	2000-06-01	Composicion de organo-polisiloxano curable con contenido de un nuevo promotor de adhesion.
GB9622590D0 (en)	1997-01-08	Chemical compounds
BRPI0403558A (pt)	2005-06-07	Método e composição para suprimir pó de carvão
DK0906276T3 (da)	2002-12-02	Nye vitamin D analoger
MY144529A (en)	2011-09-30	Additive mixtures
DE69814991D1 (de)	2003-07-03	Copolymere aus alpha-olefin und cycloolefin und verfahren zu ihrer herstellung
GB9524812D0 (en)	1996-02-07	Chemical compounds
ES8300319A1 (es)	1982-11-01	"procedimiento, para preparar deca-, undeca- y tridecapeptidos con actividad timica".
ES2044067T3 (es)	1994-01-01	Separacion de sulfuro de hidrogeno de una mezcla gaseosa.
TR199900079T2 (xx)	1999-04-21	S�v� hidrokarbon yak�t bile�imi.
ES2177943T3 (es)	2002-12-16	Complejos metal-bencenoditiol sustituidos.
ES264044A1 (es)	1961-07-01	Un metodo de reducir la corrosiën de metal en contacto con un hidrocarburo y un corroyente acido
AR048578A1 (es)	2006-05-10	Procedimiento de transformacion de un gas de sintesis en hidrocarburos en presencia de sic-beta y efluente de este procedimiento
GB1526051A (en)	1978-09-27	Compositions based on chlorofluoroalkanes and alcohols
ES450919A1 (es)	1977-08-16	Procedimiento para la preparacion de copolimeros conteniendoinsaturaciones dienicas conjugadas.